Nationwide Fund Advisors - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 124 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$1,112,000
+41.7%
64,030
+4.6%
0.00%
+33.3%
Q2 2017$785,000
-4.5%
61,195
-3.5%
0.00%0.0%
Q1 2017$822,000
+22.3%
63,411
-6.7%
0.00%0.0%
Q4 2016$672,000
-22.0%
67,997
-4.6%
0.00%
-25.0%
Q3 2016$861,000
+40.0%
71,2860.0%0.00%
+33.3%
Q2 2016$615,000
-5.5%
71,286
+3.7%
0.00%0.0%
Q1 2016$651,000
-46.2%
68,727
-1.6%
0.00%
-40.0%
Q4 2015$1,210,000
+32.0%
69,817
+2.3%
0.01%
+25.0%
Q3 2015$917,000
-41.0%
68,254
-0.7%
0.00%
-33.3%
Q2 2015$1,553,000
+43.7%
68,764
-9.2%
0.01%
+50.0%
Q1 2015$1,081,000
+41.7%
75,733
-4.2%
0.00%
+33.3%
Q4 2014$763,000
+5.1%
79,091
-0.9%
0.00%0.0%
Q3 2014$726,000
-7.4%
79,784
+0.6%
0.00%0.0%
Q2 2014$784,000
-16.9%
79,331
+6.7%
0.00%
-25.0%
Q1 2014$944,000
-8.3%
74,333
+8.2%
0.00%0.0%
Q4 2013$1,030,000
+32.2%
68,727
-2.6%
0.00%
+33.3%
Q3 2013$779,000
+45.1%
70,577
+4.4%
0.00%0.0%
Q2 2013$537,00067,6320.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$206,177,00028.12%
BB BIOTECH AG 8,322,860$121,763,0003.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 398,633$4,579,0002.84%
DOHENY ASSET MANAGEMENT /CA 227,193$3,324,0002.43%
SNYDER CAPITAL MANAGEMENT L P 2,833,759$41,458,0002.24%
First Light Asset Management, LLC 938,399$13,729,0002.19%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,027,164$132,067,0001.77%
Taylor Wealth Management Partners 204,277$2,989,0001.72%
Sterling Global Strategies LLC 22,000$321,860,0001.63%
Granite Investment Partners, LLC 988,939$14,468,0001.06%
View complete list of HALOZYME THERAPEUTICS INC shareholders